Hypertension mega trials are still being under taken. There is convincing evidence that treating blood pressure is beneficial in reducing CV end points. Does it matter which drug or drugs to be used as initiation therapy? because finally it is better control that translates to such CV benefits. I enjoyed this review article published in SMC recently..
Powered by IP2Location.com
blog comments powered by Disqus